FDA approves Zydus Lifesciences’ ZITUVIO tablets for Type 2 diabetes

Zydus Lifesciences Limited announced today that the U.S. Food and Drug Administration (FDA) has granted approval for its New Drug Application (NDA) for ZITUVIO (Sitagliptin) ... Read More